2017 annual financial data
Regencell Bioscience 2017 Operating margin
Regencell Bioscience 2017 operating margin with verified reported values.
Direct answer
Operating margin was 10.77%.
Operating income was 344,200,000 USD and net income was 170,400,000 USD.
Operating cash flow was 410,500,000 USD.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,197,100,000 USD
- Operating income
- 344,200,000 USD
- Net income
- 170,400,000 USD
- Operating cash flow
- 410,500,000 USD